PTEN Loss Is Associated with Adverse Outcomes in the Setting of Salvage Radiation Therapy

Salvage radiation therapy (SRT) is a mainstay of treatment for biochemical relapse following radical prostatectomy; however, few studies have examined genomic biomarkers in this context.